Home The reference ranges for fetal ductus venosus flow velocities and calculated waveform indices and their predictive values for right heart diseases
Article Open Access

The reference ranges for fetal ductus venosus flow velocities and calculated waveform indices and their predictive values for right heart diseases

  • Jian Wu , Yanping Ruan , Xinru Gao , Hairui Wang , Yuxuan Guan , Xiaoyan Hao , Jiancheng Han , Xiaoyan Gu EMAIL logo and Yihua He EMAIL logo
Published/Copyright: February 6, 2025

Abstract

Objectives

This study endeavors to establish comprehensive normal reference ranges and Z score formulas for ductus venosus (DV) flow velocity parameters and calculated waveform indices across different gestational ages in low-risk fetuses. Furthermore, we aim to validate the predictive capabilities of these Z score calculation formulas in fetuses with diverse right heart diseases.

Methods

A total of 8,953 singleton low-risk fetuses and 70 fetuses diagnosed with different types of right heart diseases were retrospectively enrolled. The DV blood flow velocities during the cardiac cycle (ventricular systolic wave velocity [S], ventricular diastolic wave velocity [D], atrial contraction wave velocity [A], and time-averaged maximum velocity [Tamx]) and calculated waveform indices (preload index [PLI], peak velocity index [PVI], pulsatility index [PI], S/A, and S/D) were obtained. Ninety low-risk fetuses were randomly selected as the control group to verify the predictive value of the Z score model for fetuses with different types of right heart diseases.

Results

As gestational age increased (16–39 weeks), the mean values of S, D, A, and Tamx progressively increased; conversely, the mean values of PLI, PVI, PI, and S/A decreased, respectively, and the median value of S/D remained stable. The Z score-transformed A, PLI, PVI, PI, and S/A could serve as predictors of overall right heart diseases. Different DV Doppler parameter Z scores exhibited varying predictive values for different subtypes of right heart diseases.

Conclusions

Normal reference ranges and corresponding Z score calculation formulas for DV hemodynamic parameters were established, which have demonstrated significant diagnostic values in identifying right heart diseases.

Introduction

Fetal right heart function and hemodynamic analysis play crucial roles in fetal prognosis [1]. Traditional evaluation indicators of fetal right heart function, such as tricuspid annular plane systolic excursion, right ventricular fractional area change, tissue Doppler tricuspid annular systolic velocity (TDI-S′), pulsed wave Doppler velocity of tricuspid blood flow (E and A) and their ratio (E/A), as well as tissue Doppler velocity of tricuspid annulus (E′ and A′) and their ratio (E’/A′), are predominantly utilized to assess systolic and/or diastolic function. However, due to the shunt of the foramen ovale in the fetal period, these indicators cannot reflect the comprehensive right heart function or hemodynamics over different cardiac cycles. Umbilical vein oxygenated blood crosses into the right heart through the ductus venosus (DV). Alterations in right heart preload, afterload, or function can influence DV hemodynamics. Doppler flow assessments of the DV are significant in assessing different cardiac conditions and fetal circulatory. Consequently, the DV Doppler spectrum has the potential to provide valuable information for the evaluation of the overall right heart function and hemodynamics [2], 3].

However, at present, there are no normal reference ranges and Z score calculation formulas for DV Doppler spectrum parameters based on large sample size, and there is a lack of systematic disease efficacy validation. Beijing Anzhen Hospital, as a national referral center for fetal cardiovascular diseases, has established a large sample database [4]. At our center, the fetal disease-positive rate reached 27 %, and the diagnostic accuracy of severe heart malformations was 98.8 % [5]. Based on the database, this study aims to 1) establish the normal reference ranges for fetal DV hemodynamic parameters and the corresponding Z score calculation formulas; and 2) verify the predictive values of these DV Z score calculation formulas in fetal right heart diseases.

Materials and methods

Study population

A total of 25,607 fetal data from the Maternal-Fetal Medicine Center in Fetal Heart Disease of Beijing Anzhen Hospital, spanning from November 2019 to April 2024, were retrospectively analyzed. The study process is illustrated in Figure 1. The gestational age was calculated from the last menstrual period and corroborated with the biparietal diameter and femur length.

Figure 1: 
Study flow.
Figure 1:

Study flow.

Inclusion criteria for low-risk fetuses: (1) maternal age≥18 years, (2) singleton pregnancy, (3) no maternal high-risk factors, (4) second or third trimester of pregnancy, (5) no fetal intracardiac or extracardiac abnormalities. The exclusion criteria included: (1) poor echocardiography or DV Doppler spectrum image quality, (2) fetal chromosome abnormalities, (3) fetal intrauterine growth restriction.

Inclusion criteria for fetuses with right heart diseases: (1) maternal age≥18 years, (2) second or third trimester of pregnancy, (3) diseases causing fetal right heart preload or afterload increase, or cardiomyopathy involving the right heart. The exclusion criteria included: (1) poor echocardiography or DV Doppler spectrum image quality, (2) fetal extracardiac abnormalities.

The study protocols followed the principles of the Declaration of Helsinki and were approved by the Ethics Committee, and the requirement for written informed consents from the prospective parents were waived by the Ethics Committee.

Acquisition of Doppler spectrum and measurement parameters for DV

The ultrasound diagnostic instruments used were the Voluson E8 (GE Healthcare, Milwaukee, Wisconsin, USA), Voluson E10 (GE Healthcare, Zipf, Austria), and HERA XM10 (SAMSUNG MEDISON, Gang-won-do, Korea), all equipped with 2–9 MHz frequency probes. The acquisition of fetal echocardiography adhered to the guidelines of the American Society of Echocardiography, and the International Society of Ultrasound in Obstetrics and Gynecology [6], [7], [8], [9], [10].

After adjusting the Doppler velocity scale, gain, and wall filter in the absence of fetal breathing and limb movements. Doppler measurements were performed in the sagittal plane through the upper fetal abdomen or the oblique transverse section of the fetal abdomen. The pulsed Doppler sampling volume was then adjusted according to the vessel diameter. When the sampling frame direction and the DV flow direction were less than 30°, the DV Doppler waveforms (over three cardiac cycles) were recorded: peak forward velocity (S) during ventricular contraction period, peak forward velocity (D) during early diastole period, and minimum forward velocity (A) during late diastolic atrial contraction period (Figure 2) [11]. Additionally, the time-averaged maximum velocity (Tamx) was calculated, and the following calculated waveform indices were measured: preload index (PLI), calculated as (S−A)/S; venous peak velocity index (PVI), calculated as (S−A)/D; venous pulsatility index (PI), calculated as (S−A)/Tamx [12]; S/D ratio and S/A ratio.

Figure 2: 
Color Doppler flow imaging and spectral Doppler waveform of the ductus venosus. S and D represent peak ventricular systolic and diastolic forward velocities, respectively, and A represents minimum atrial systolic velocities.
Figure 2:

Color Doppler flow imaging and spectral Doppler waveform of the ductus venosus. S and D represent peak ventricular systolic and diastolic forward velocities, respectively, and A represents minimum atrial systolic velocities.

All images, measurements, and clinical data were archived in the database.

Statistical analysis

All data were analyzed using R software (version 4.3.2) and SPSS software (version 26.0), with p<0.05 indicating statistical significance. Categorical variables were expressed as the numbers (percentage). Continuous variables were tested for normality by the Kolmogorov-Smirnov test. Continuous numerical variables were expressed as mean±standard deviation (SD) or median (interquartile range, IQR) regression model. The correlation between the DV Doppler parameter and gestational age was calculated by Spearman correlation analysis. Regression analysis was performed on DV hemodynamic parameters to determine the best-fitting equation. If the DV Doppler parameter was significantly correlated with gestational age, a univariate linear or univariate multiple linear mean regression model was established; otherwise, a quantile regression model was used to obtain the median, 5th percentile, and 95th percentile values.

The Akaike information criterion (AIC) was used to compare the relative goodness of fit of different models, and the model was selected according to the AIC value and the simplicity of the model. The Durbin-Watson test method was used to detect whether the residual term in the linear mean regression model was autocorrelated, the Q–Q Plot was used to assess the residual normality of the linear regression model, and the residuals vs. fitted values Plot was used to detect the residual variance homogeneity of the linear regression model. To construct the 5th and 95th percentile regression lines with the same slope as the mean regression line, the following calculation method was adopted: mean regression line plus/minus 1.645 times the SD of the residuals. Z score=(observation value−mean value [derived from the prediction model])/SD. The Z score of DV Doppler parameters of 90 low-risk fetuses (randomly selected) and 70 fetuses with right heart diseases were calculated according to Z score calculation. Receiver operating characteristic (ROC) curves were used to determine the best cut-off values for predicting right heart diseases. The intraclass correlation coefficient and Bland-Altman analyses were used to estimate intra- and inter-observer variation in DV Doppler parameters among 20 randomly selected subjects.

Results

Clinical characteristics

After applying the inclusion and exclusion criteria, 8,953 low-risk fetuses and 70 fetuses with right heart diseases were finally included. The clinical characteristics of low-risk fetuses and fetuses with right heart disease are summarized in Table 1. The distribution of fetal right heart diseases was as follows:

  1. Diseases with increased right heart preload (25 cases):

    1. Ebstein’s anomaly with varying degrees of tricuspid regurgitation (13 cases)

    2. Massive tricuspid regurgitation without Ebstein’s anomaly (12 cases)

  2. Diseases with increased right heart afterload (27 cases):

    1. Pulmonary stenosis with reverse perfusion of the ductus arteriosus (nine cases)

    2. Pulmonary atresia with intact ventricular septum (18 cases)

  3. Cardiomyopathy involving the right heart (18 cases):

    1. Excessive myocardial trabeculation (11 cases)

    2. Endocardial fibroelastosis (seven cases)

Table 1:

Characteristics of the study population.

Variable Low-risk group (n=8,953) Right heart disease group (n=70)
Right heart disease (n=70) Increased right heart preload (n=25) Increased right heart afterload (n=27) Cardiomyopathy involving the right heart (n=18)
Ethnicity
 Han ethnicity 8,711 (97.3 %) 70 (100 %) 25 (100 %) 27 (100 %) 18 (100 %)
 Others 242 (2.7 %) 0 (0 %) 0 (0 %) 0 (0 %) 0 (0 %)
Maternal age, years 32 (29–35) 30 (28–33) 31 (27–33) 31 (29–37) 30 (28–32)
Fetal gestational age, weeks 24.9 (24.3–26.0) 25.2 (23.9–28.5) 28.6 (24.5–31.4) 24.0 (23.6–25.3) 26.4 (24.3–28.1)
Fetal heart rate, bpm 148 (143–153) 146 (141–150) 146 (143–150) 148 (142–152) 144 (130–149)
Biparietal diameter, mm 62 (59–66) 65 (58–74) 76 (65–85) 58 (56–63) 68 (61–73)
Femur length, mm 44 (42–47) 46 (41–54) 55 (44–60) 42 (40–46) 48 (43–53)
  1. Data are expressed as median (interquartile range) or number (percentage), appropriately.

Normal reference ranges and Z score calculation formulas for DV hemodynamic parameters

The S, D, A, Tamx, PLI, PVI, PI, and S/A were all significantly correlated with gestational age (all p<0.001), whereas S/D was not significantly correlated with gestational age (p=0.051) (Supplemental Table S1). Univariate linear regression models were established for S, D, A, and Tamx; similarly, univariate quadratic linear regression models were also established for PLI, PVI, PI, and S/A (Table 2). For S/D, a quantile regression model was established, yielding the 5th percentile value of 1.00, the 50th percentile value of 1.10, and the 95th percentile value of 1.32.

Table 2:

Regression equations for ductus venosus Doppler indices (n=8,953).

Predicted 5th percentile Predicted mean Predicted 95th percentile
S, cm/s 0.7196 × GA+7.4024 0.7196 × GA+30.3822 0.7196 × GA+53.3620
D, cm/s 0.5772 × GA+7.8143 0.5772 × GA+28.9735 0.5772 × GA+50.1327
A, cm/s 0.8151 × GA−8.2940 0.8151 × GA+6.7210 0.8151 × GA+21.7360
Tamx, cm/s 0.6858 × GA+4.1309 0.6858 × GA+24.2328 0.6858 × GA+44.3347
PLI 0.00046 × GA2−0.0330 × GA+0.8016 0.00046 × GA2−0.0330 × GA+0.9750 0.00046 × GA2−0.0330 × GA+1.1484
PVI 0.00070 × GA2−0.0462 × GA+0.9846 0.00070 × GA2−0.0462 × GA+1.2122 0.00070 × GA2−0.0462 × GA+1.4398
PI 0.00062 × GA2−0.0438 × GA+0.9889 0.00062 × GA2−0.0438 × GA+1.2269 0.00062 × GA2−0.0438 × GA+1.4649
S/A 0.00233 × GA2−0.1541 × GA+3.6046 0.00233 × GA2−0.1541 × GA+4.2369 0.00233 × GA2−0.1541 × GA+4.8691
  1. A, atrial contraction wave velocity; D, ventricular diastole wave velocity; GA, gestational age; PI, pulsatility index; PLI, preload index; PVI, peak velocity index; S, ventricular systole wave velocity; S/A, ventricular systole/atrial contraction wave velocity ratio; Tamx, time-averaged maximum velocity.

Reference ranges for the 5th percentile, mean, and 95th percentile values of the S, D, A, Tamx, PLI, PVI, PI, and S/A for DV at 16–39 weeks of gestation were established, as shown in Figure 3, Figure 4, Table 3, and Table 4. As gestational age increased, the mean values of the S, D, A, and Tamx increased from 41.9 cm/s to 58.5 cm/s, from 38.2 cm/s to 51.5 cm/s, from 19.8 cm/s to 38.5 cm/s, and from 35.2 cm/s to 51.0 cm/s, respectively. Conversely, as gestational age increased, the mean values of the PLI, PVI, PI, and S/A decreased from 0.57 to 0.39, from 0.65 to 0.475, from 0.69 to 0.46, and from 2.37 to 1.77, respectively.

Figure 3: 
Scatter plots and reference range interval plots of the S, D, A, and Tamx. The solid line represents the mean predicted value and the dashed lines represents the 5th and 95th percentile predicted values. A, atrial contraction wave velocity; D, ventricular diastole wave velocity; GA, gestational age; S, ventricular systole wave velocity; Tamx, time-averaged maximum velocity.
Figure 3:

Scatter plots and reference range interval plots of the S, D, A, and Tamx. The solid line represents the mean predicted value and the dashed lines represents the 5th and 95th percentile predicted values. A, atrial contraction wave velocity; D, ventricular diastole wave velocity; GA, gestational age; S, ventricular systole wave velocity; Tamx, time-averaged maximum velocity.

Figure 4: 
Scatter plots and reference range interval plots of the PLI, PVI, PI, and S/A. The solid line represents the mean predicted value and the dashed lines represents the 5th and 95th predicted percentile values. GA, gestational age; PI, pulsatility index; PLI, preload index; PVI, peak velocity index; S/A, ventricular systole/atrial contraction wave velocity ratio.
Figure 4:

Scatter plots and reference range interval plots of the PLI, PVI, PI, and S/A. The solid line represents the mean predicted value and the dashed lines represents the 5th and 95th predicted percentile values. GA, gestational age; PI, pulsatility index; PLI, preload index; PVI, peak velocity index; S/A, ventricular systole/atrial contraction wave velocity ratio.

Table 3:

Reference ranges for predicting gestational age-related ductus venosus blood flow velocities (n=8,953).

GA, wk S, cm/s D, cm/s A, cm/s Tamx, cm/s
5th percentile Mean 95th percentile 5th percentile Mean 95th percentile 5th percentile Mean 95th percentile 5th percentile Mean 95th percentile
16 18.92 41.90 64.88 17.05 38.21 59.37 4.75 19.76 34.78 15.10 35.21 55.31
17 19.64 42.62 65.60 17.63 38.79 59.95 5.56 20.58 35.59 15.79 35.89 55.99
18 20.36 43.34 66.31 18.20 39.36 60.52 6.38 21.39 36.41 16.48 36.58 56.68
19 21.07 44.05 67.03 18.78 39.94 61.10 7.19 22.21 37.22 17.16 37.26 57.36
20 21.79 44.77 67.75 19.36 40.52 61.68 8.01 23.02 38.04 17.85 37.95 58.05
21 22.51 45.49 68.47 19.94 41.09 62.25 8.82 23.84 38.85 18.53 38.63 58.74
22 23.23 46.21 69.19 20.51 41.67 62.83 9.64 24.65 39.67 19.22 39.32 59.42
23 23.95 46.93 69.91 21.09 42.25 63.41 10.45 25.47 40.48 19.90 40.01 60.11
24 24.67 47.65 70.63 21.67 42.83 63.99 11.27 26.28 41.30 20.59 40.69 60.79
25 25.39 48.37 71.35 22.24 43.40 64.56 12.08 27.10 42.11 21.28 41.38 61.48
26 26.11 49.09 72.07 22.82 43.98 65.14 12.90 27.91 42.93 21.96 42.06 62.17
27 26.83 49.81 72.79 23.40 44.56 65.72 13.71 28.73 43.74 22.65 42.75 62.85
28 27.55 50.53 73.51 23.98 45.14 66.29 14.53 29.54 44.56 23.33 43.44 63.54
29 28.27 51.25 74.23 24.55 45.71 66.87 15.34 30.36 45.37 24.02 44.12 64.22
30 28.99 51.97 74.95 25.13 46.29 67.45 16.16 31.17 46.19 24.70 44.81 64.91
31 29.71 52.69 75.67 25.71 46.87 68.03 16.97 31.99 47.00 25.39 45.49 65.59
32 30.43 53.41 76.39 26.28 47.44 68.60 17.79 32.80 47.82 26.08 46.18 66.28
33 31.15 54.13 77.11 26.86 48.02 69.18 18.60 33.62 48.63 26.76 46.86 66.97
34 31.87 54.85 77.83 27.44 48.60 69.76 19.42 34.43 49.45 27.45 47.55 67.65
35 32.59 55.57 78.55 28.02 49.18 70.33 20.23 35.25 50.26 28.13 48.24 68.34
36 33.31 56.29 79.27 28.59 49.75 70.91 21.05 36.06 51.08 28.82 48.92 69.02
37 34.03 57.01 79.99 29.17 50.33 71.49 21.86 36.88 51.89 29.51 49.61 69.71
38 34.75 57.73 80.71 29.75 50.91 72.07 22.68 37.69 52.71 30.19 50.29 70.40
39 35.47 58.45 81.43 30.33 51.48 72.64 23.49 38.51 53.52 30.88 50.98 71.08
  1. A, atrial contraction wave velocity; D, ventricular diastole wave velocity; GA, gestational age; S, ventricular systole wave velocity; Tamx, time-averaged maximum velocity.

Table 4:

Reference ranges for predicting gestational age-related ductus venosus calculated waveform indices (n=8,953).

GA, wk PLI PVI PI S/A
5th percentile Mean 95th percentile 5th percentile Mean 95th percentile 5th percentile Mean 95th percentile 5th percentile Mean 95th percentile
16 0.391 0.565 0.738 0.425 0.652 0.880 0.447 0.685 0.923 1.735 2.368 3.000
17 0.374 0.547 0.720 0.402 0.629 0.857 0.423 0.661 0.899 1.658 2.291 2.923
18 0.357 0.530 0.703 0.380 0.607 0.835 0.401 0.639 0.877 1.586 2.218 2.850
19 0.341 0.514 0.687 0.360 0.587 0.815 0.381 0.619 0.857 1.518 2.150 2.782
20 0.326 0.499 0.672 0.341 0.568 0.796 0.361 0.599 0.837 1.455 2.087 2.719
21 0.311 0.485 0.658 0.323 0.551 0.778 0.343 0.581 0.819 1.396 2.028 2.661
22 0.298 0.472 0.645 0.307 0.535 0.762 0.325 0.563 0.801 1.342 1.974 2.607
23 0.286 0.459 0.633 0.292 0.520 0.748 0.309 0.547 0.785 1.293 1.925 2.557
24 0.275 0.448 0.621 0.279 0.507 0.734 0.295 0.533 0.771 1.248 1.881 2.513
25 0.264 0.438 0.611 0.267 0.495 0.722 0.281 0.519 0.757 1.208 1.841 2.473
26 0.255 0.428 0.601 0.257 0.484 0.712 0.269 0.507 0.745 1.173 1.805 2.438
27 0.246 0.419 0.593 0.248 0.475 0.703 0.258 0.496 0.734 1.142 1.775 2.407
28 0.238 0.412 0.585 0.240 0.467 0.695 0.249 0.487 0.725 1.117 1.749 2.381
29 0.231 0.405 0.578 0.234 0.461 0.689 0.240 0.478 0.716 1.095 1.728 2.360
30 0.226 0.399 0.572 0.229 0.456 0.684 0.233 0.471 0.709 1.079 1.711 2.343
31 0.221 0.394 0.567 0.225 0.453 0.680 0.227 0.465 0.703 1.067 1.699 2.331
32 0.217 0.390 0.563 0.223 0.451 0.678 0.222 0.460 0.698 1.059 1.692 2.324
33 0.214 0.387 0.560 0.222 0.450 0.678 0.219 0.457 0.695 1.057 1.689 2.321
34 0.211 0.385 0.558 0.223 0.451 0.678 0.216 0.454 0.692 1.059 1.691 2.323
35 0.210 0.384 0.557 0.225 0.453 0.680 0.215 0.453 0.691 1.065 1.698 2.330
36 0.210 0.383 0.557 0.229 0.456 0.684 0.216 0.454 0.692 1.077 1.709 2.341
37 0.210 0.384 0.557 0.234 0.461 0.689 0.217 0.455 0.693 1.093 1.725 2.357
38 0.212 0.385 0.559 0.240 0.467 0.695 0.220 0.458 0.696 1.113 1.746 2.378
39 0.214 0.388 0.561 0.248 0.475 0.703 0.224 0.462 0.700 1.139 1.771 2.403
  1. GA, gestational age; PI, pulsatility index; PLI, preload index; PVI, peak velocity index; S/A, ventricular systole/atrial contraction wave velocity ratio.

Based on the best linear fitting regression equations and residual SD between DV blood flow velocity and calculated waveform indices against the gestational age, the Z score calculation formulas were established for 8 DV Doppler parameters (S, D, A, Tamx, PLI, PVI, PI, and S/A) (Table 5). Taking the Z score (S) as an example, Z score (S)=[observation value−(0.7196 × gestational age+30.3822)]/13.9695.

Table 5:

Table 5Z score regression equations of ductus venosus Doppler parameters.

Z-score regression equation
S Z = S value ( 0.7196 * GA + 30.3822 ) 13.9695
D Z = D value ( 0.5772 * GA + 28.9735 ) 12.8627
A Z = A value ( 0.8151 * GA + 6.7210 ) 9.1277
Tamx Z = Tamx value ( 0.6858 * GA + 24.2328 ) 12.2200
PLI Z = PLI value ( 0.00046 * GA 2 + 0.0330 * GA + 0.9750 ) 0.1054
PVI Z = PVI value ( 0.00070 * GA 2 + 0.0462 * GA + 1.2122 ) 0.1384
PI Z = PI value ( 0.00062 * GA 2 + 0.0438 * GA + 1.2269 ) 0.1447
S/A Z = S / A value ( 0.00233 * GA 2 + 0.1541 * GA + 4.2369 ) 0.3843
  1. A, atrial contraction wave velocity; D, ventricular diastole wave velocity; GA, gestational age; PI, pulsatility index; PLI, preload index; PVI, peak velocity index; S, ventricular systole wave velocity; S/A, ventricular systole/atrial contraction wave velocity ratio; Tamx, time-averaged maximum velocity.

Diagnostic efficacies of Z score evaluation system in right heart diseases

Comparisons of the Z scores of DV hemodynamic parameters are shown in Table 6 between the fetuses in the control group and those in the overall group with right heart diseases, the group with increased right heart preload, the group with increased right heart afterload, and the group with cardiomyopathy involving the right heart. The Z score (A) of the overall group with right heart diseases was significantly reduced (p=0.001), and the Z scores of the PLI, PVI, PI, and S/A were all significantly increased (all p<0.001).

Table 6:

Comparisons of Z scores of ductus venosus Doppler parameters between normal controls and patients with right heart disease.

Variables-Z score Control (n=90) Right heart disease group (n=70) p (compared with control)
Right heart disease (n=70) Increased right heart preload (n=25) Increased right heart afterload (n=27) Cardiomyopathy involving the right heart (n=18)
S −0.167±1.023 −0.006±1.018 −0.291±0.899 −0.074±0.933 0.272±1.234
D −0.229±0.965 −0.133±0.989 −0.335±0.779 −0.075±1.035 0.061±1.172
A −0.220 (−0.974 to 0.568) −0.890 (−1.450 to −0.236) −0.706 (−1.143 to −0.162) −1.183 (−1.789 to −0.462) −0.643 (−1.472 to 0.873) a,c
Tamx −0.112 (−0.955 to 0.525) −0.277 (−0.975 to 0.307) −0.606 (−1.053 to 0.150) −0.174 (−0.886 to 0.280) −0.134 (−0.915 to 0.890)
PLI 0.080 (−0.566 to 0.703) 0.855 (0.083 to 2.122) 0.417 (−0.194 to 0.992) 1.549 (0.611 to 3.269) 1.023 (0.060 to 2.509) a,b,c,d
PVI −0.009 (−0.542 to 0.798) 0.809 (−0.139 to 2.370) 0.269 (−0.338 to 0.809) 1.790 (0.374 to 3.531) 1.205 (−0.135 to 2.501) a,c,d
PI −0.067 (−0.766 to 0.522) 0.981 (−0.005 to 2.201) 0.547 (−0.233 to 0.981) 1.667 (1.024 to 3.346) 0.813 (−0.105 to 2.964) a,b,c,d
S/A −0.098 (−0.631 to 0.536) 0.624 (−0.150 to 2.707) 0.228 (−0.351 to 0.747) 1.693 (0.406 to 7.730) 0.497 (−0.245 to 3.225) a,c,d
  1. Data are presented as mean±SD or median (interquartile range). A, atrial contraction wave velocity; D, ventricular diastole wave velocity; PI, pulsatility index; PLI, preload index; PVI, peak velocity index; S, ventricular systole wave velocity; S/A, ventricular systole/atrial contraction wave velocity ratio; Tamx, time-averaged maximum velocity. a – Significant difference between control group and overall group with right heart disease, b – significant difference between control group and group with increased right heart preload, c – significant difference between control group and group with increased right heart afterload, d – significant difference between control group and group with cardiomyopathy involving the right heart.

By ROC analysis, the Z scores of each parameter were determined to be able to predict different types of right heart diseases in the fetus (Figure 5). ROC analysis of statistically significant parameters:

  1. The best cut-off values for the Z scores of the A, PLI, PVI, PI, and S/A in the overall group of right heart diseases were −0.191 (area under receiver operating characteristic curve [AUC]=0.655, sensitivity=77.1 %, and specificity=50.0 %), 0.415 (AUC=0.720, sensitivity=67.1 %, and specificity=67.8 %), 1.189 (AUC=0.697, sensitivity=44.3 % and specificity=90.0 %), 0.546 (AUC=0.740, sensitivity=64.3 % and specificity=81.1 %), and 0.226 (AUC=0.689, sensitivity=64.3 %, and specificity=67.9 %), respectively (Supplemental Table S2).

  2. The best cut-off values for the Z scores of the PLI and PI for right preload diseases were −0.365 (AUC=0.638, sensitivity=96.0 %, and specificity=33.3 %) and 0.716 (AUC=0.660, sensitivity=52.0 %, and specificity=81.1 %), respectively (Supplemental Table S3).

  3. The best cut-off values for the Z scores of the A, PLI, PVI, PI, and S/A for right heart afterload-increasing diseases were −0.998 (AUC=0.734, sensitivity=63.0 %, and specificity=78.9 %), 1.381 (AUC=0.803, sensitivity=59.3 %, and specificity=93.3 %), 1.240 (AUC=0.791, sensitivity=63.0 %, and specificity=90.0 %), 0.840 (AUC=0.830, sensitivity=81.5 %, and specificity=84.4 %), and 0.987 (AUC=0.806, sensitivity=63.0 %, and specificity=91.1 %), respectively (Supplemental Table S4).

  4. The best cut-off values for the Z scores of the PLI, PVI, PI, and S/A for cardiomyopathy involving the right heart were 1.201 (AUC=0.708, sensitivity=50.0 %, and specificity=92.2 %), 1.189 (AUC=0.712, sensitivity=55.6 % and, specificity=92.2 %), 0.525 (AUC=0.717, sensitivity=61.1 %, and specificity=75.6 %), and 1.043 (AUC=0.654, sensitivity=44.4 %, and specificity=91.1 %), respectively (Supplemental Table S5).

Figure 5: 
ROC analysis. (A) Receiver operating characteristic analysis of Z scores of ductus venous hemodynamic parameters for predicting right heart disease. (B) Receiver operating characteristic analysis of Z scores of ductus venous hemodynamic parameters for predicting increased right heart preload. (C) Receiver operating characteristic analysis of Z scores of ductus venous hemodynamic parameters for predicting increased right heart afterload. (D) Receiver operating characteristic analysis of Z scores of ductus venous hemodynamic parameters for predicting cardiomyopathy involving the right heart.
Figure 5:

ROC analysis. (A) Receiver operating characteristic analysis of Z scores of ductus venous hemodynamic parameters for predicting right heart disease. (B) Receiver operating characteristic analysis of Z scores of ductus venous hemodynamic parameters for predicting increased right heart preload. (C) Receiver operating characteristic analysis of Z scores of ductus venous hemodynamic parameters for predicting increased right heart afterload. (D) Receiver operating characteristic analysis of Z scores of ductus venous hemodynamic parameters for predicting cardiomyopathy involving the right heart.

Intra-observer and inter-observer variabilities

Intra- and inter-observer variabilities of DV hemodynamic parameters are summarized in Table 7, Supplemental Figures S1 and S2, showing good reproducibility.

Table 7:

Intra- and inter-observer variabilities of ductus venosus Doppler parameters.

Intra-observer variability (n=20) Inter-observer variability (n=20)
Bias 95 % CI ICC Bias 95 % CI ICC
S, cm/s −0.100 −6.736 to 6.536 0.964 −0.075 −6.812 to 6.662 0.962
D, cm/s 0.500 −5.682 to 6.682 0.960 0.775 −4.688 to 6.238 0.969
A, cm/s 1.150 −3.787 to 6.087 0.975 0.475 −4.285 to 5.235 0.985
Tamx, cm/s −1.530 −10.052 to 6.992 0.956 −0.843 −8.735 to 7.050 0.935
PLI −0.028 −0.106 to 0.050 0.952 −0.013 −0.090 to 0.064 0.940
PVI −0.044 −0.173 to 0.086 0.928 −0.035 −0.164 to 0.094 0.865
PI −0.011 −0.091 to 0.069 0.951 −0.005 −0.093 to 0.083 0.959
S/A −0.093 −0.359 to 0.174 0.960 −0.035 −0.332 to 0.261 0.905
S/D −0.019 −0.119 to 0.081 0.885 −0.026 −0.112 to 0.061 0.837
  1. A, atrial contraction wave velocity; D, ventricular diastole wave velocity; PI, pulsatility index; PLI, preload index; PVI, peak velocity index; S, ventricular systole velocity; S/A, ventricular systole/atrial contraction wave velocity ratio; S/D, ventricular systole/ventricular diastole wave velocity ratio; Tamx, time-averaged maximum velocity.

Discussion

The comprehensive evaluation of the global function of the right heart is important for perinatal management. Theoretically, the DV Doppler spectrum parameters can reflect changes in the overall function and hemodynamics of the right heart. The S, D, and A in the DV Doppler spectrum reflect the rapid changes in the pressure gradient timing between the umbilical vein and the right atrium. Additionally, while measurements of DV blood flow velocity parameters may change with different angles, the calculated waveform indices are angle-independent and represent stable parameters for evaluating DV hemodynamics [13].

The DV blood flow Doppler spectra change with gestational ages. Although some studies of reference ranges for DV hemodynamic parameters have been reported previously, these studies were limited by small sample sizes, incomplete measurement parameters, the absence of Z score calculation formulas, or difficulty in widely using ultrasound for routine screening and diagnosis [14], [15], [16], [17], [18], [19], [20], [21]. Relying on the largest multi-center database in China, the normal reference ranges of nine parameters of low-risk fetal DV hemodynamics at 16–39 weeks of gestation were established, and the Z score calculation formulas of 8 DV hemodynamic parameters were established to facilitate clinical applications. During weeks 16–39, with the increase in gestational age, the S, D, A, and Tamx increased, while the PLI, PVI, PI, and S/A ratio decreased, with the S/D ratio remaining unchanged. The changing trends of the above parameters were similar to the results of studies by Bahlmann et al., Suksai et al., Tongprasert et al., and Rizzo et al. [14], 19], [21], [22], [23]. In this study, the S, D, A, PLI, and PVI were slightly lower compared to those reported by Bahlmann et al. [14]. Furthermore, the reference ranges calculated in our study were broader than those reported by Bahlmann et al. Additionally, the PLI, PVI, and PI in this study were lower than those documented by Tongprasert et al. and Rizzo et al. [21], 23]. Regarding the reference ranges for calculated waveform indices, our findings were comparable to those reported by Tongprasert et al., yet narrower than those reported by Rizzo et al. The variation observed is probably attributable to the statistical methods employed in establishing the reference range, the different ethnicities, and the differing sizes of the population cohorts. This study further validated the diagnostic value of the Z score calculating evaluation system of DV hemodynamic parameters in predicting right heart diseases.

Influencing factors of fetal right heart function and hemodynamics

The primary influencing factors of right heart function and hemodynamics in the fetal period are increased right heart preload, increased right heart afterload, and cardiomyopathy involving the right heart. When the right heart preload increases, the right heart expands to compensate, leading to an increase in myocardial tone. If the preload remains elevated for an extended period, the afterload also increases. When the right heart afterload increases, the initial response of the right ventricle is adaptive remodeling, with the myocardium thickening to enhance contractility. However, if the pressure is too high or persists for too long, the right heart decompensates, and the right heart function significantly decreases, potentially resulting in right heart failure [24]. Cardiomyopathy affecting the right heart directly impairs the normal systolic and diastolic function of cardiomyocytes, reducing right heart function. This, in turn, hinders the flow of peripheral blood back into the atrium and its efficient pumping out of the ventricle. The fetal right heart myocardium is immature, which inherently elevates the risk of right heart failure and adverse pregnancy outcomes in the presence of right heart diseases [1]. During the fetal period, due to the presence of the foramen ovale and the ductus arteriosus, previous partial function evaluation parameters cannot comprehensively evaluate the overall right heart function and hemodynamics. The DV is located at the opening of the inferior vena cava entering the right atrium. The DV integrates the overall pressure and flow shunt outcome of the right atrium, right ventricle, foramen ovale, and ductus arteriosus, which can theoretically accurately and comprehensively evaluate right heart function and hemodynamics. Moreover, the S, D, and A in the DV Doppler spectrum reflect the function and hemodynamics of ventricular systole, ventricular diastole, and atrial systole during the cardiac cycle. Furthermore, multiple calculated waveform indices of the blood flow Doppler spectrum can also indirectly reflect differences in the right heart volume load, pressure load, and primary myocardial abnormalities.

This study suggests that the S, D, and Tamx may not be sensitive parameters for evaluating right heart disease changes. When the right heart afterload increases, ventricular end-diastolic pressure also rises, leading to an increase in forward blood flow impedance. Under this condition, the A wave exhibits a significant reduction, absence, or reversal [25]. Regarding the DV calculation waveform indices, the Z scores of the PLI and PI were significantly higher than those of the control group when the right heart preload increased; and the Z scores of the PLI, PVI, PI, and S/A were significantly higher in the increased right heart afterload group and the group with cardiomyopathy involving the right heart. This indicates that the angle-independent DV calculation waveform indices are more sensitive to the hemodynamic changes in the DV caused by different right heart diseases than the flow velocity parameters. Therefore, these indices should be used clinically as valuable evaluation indices for assessing the hemodynamic states of the fetal right heart.

The Z scores of the PLI and PI have moderate diagnostic values for the overall right heart diseases (PLI: AUC=0.720, PI: AUC=0.740, respectively). However, for screening overall right heart diseases, the efficiency of DV Doppler parameters is not high. This may be because when screening for right heart diseases as a whole, which encompasses various causes of right heart function and/or hemodynamic changes, the changes in DV hemodynamic parameters are inconsistent. The Z scores of the PLI and PI have low diagnostic values for diseases with increased right preload (PLI: AUC=0.638, PI: AUC=0.660, respectively). For the specific diagnosis of diseases with increased right preload, the diagnostic efficacies of DV hemodynamic parameters are low. This may be attributed to the compensatory enhancement of right myocardial contractility, increased blood output, and no significant change in right heart blood return when the right heart volume load increases, resulting in insignificant changes in DV hemodynamic parameters of the right heart [24], 26]. The Z scores of the PLI, PI, and S/A have high diagnostic values for diseases with increased right heart afterload (PLI: AUC=0.803, PI: AUC=0.830, S/A: AUC=0.806, respectively). Compared with increased right heart volume load, right heart pressure load is insufficient to compensate for right heart function, leading to significant blockage of right heart forward blood flow and notable hemodynamic changes in each phase, which results in significant changes in DV hemodynamic parameters [27]. The Z scores of the PLI, PVI, and PI have moderate diagnostic values for diseases involving right heart cardiomyopathy (PLI: AUC=0.708, PVI: AUC=0.712, PI: AUC=0.717, respectively). For the specific diagnosis of diseases involving right heart cardiomyopathy, the diagnostic efficacy of DV hemodynamic parameters is not high. This may be due to the low degree of fetal right heart function and hemodynamics change caused by right heart cardiomyopathy, thus resulting in no high diagnostic efficacy for diseases involving right heart cardiomyopathy.

Strengths and limitations

This study is the largest sample size to date in investigating the hemodynamic parameters of low-risk fetal DVs. The DV measurement parameters were relatively comprehensive, and the established parameter Z score calculation formulas provide convenient references for effectively assessing whether the DV Doppler parameters of different gestational ages are normal in clinical practice. Previous studies have only observed the A reduction and direction reversal of fetal DVs with partial right heart afterload increase, and only used PVI as the parameter to predict increased right heart afterload [28]. We are the first to validate the predictive values of the Z score calculation formulas for multiple hemodynamic parameters of the DV in fetal right heart diseases.

This study is a retrospective, cross-sectional analysis (only select one recording for the included fetuses). The sample size of each gestational age is not uniformly distributed (predominantly concentrated around 25 weeks), which may influence the accuracy of the regression equation construction. All fetuses included in the study were Chinese; thus, the established normal reference ranges may not be applicable to populations in other countries. The number of cases included is small and the diversity of case types is relatively small. Further expansion of the sample size and inclusion of a wider range of case types is necessary. Lastly, although our center is the national referral center for fetal heart disease, prospective multi-center validation is the next step in our research plan.

Conclusions

Based on the low-risk fetal population, this study has established the normal reference ranges of DV hemodynamic parameters at 16–39 gestational weeks and developed clinically applicable Z score calculation formulas. These Z score calculation formulas have been verified for their potential application in predicting right heart diseases indicating their guiding value of fetal right heart disease screening. However, further research is necessary to comprehensively evaluate the application values of these reference values and Z score calculation formulas in other diseases.


Corresponding authors: Xiaoyan Gu and Yihua He, Maternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China, E-mail: (X. Gu), (Y. He)
Jian Wu, Yanping Ruan, and Xinru Gao contributed equally to the work. Yihua He and Xiaoyan Gu contributed equally to this work and share first authorship.

Funding source: Dengfeng project of talent training plan of Beijing Medical Management Center

Award Identifier / Grant number: DFL20220601

Funding source: Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease

Award Identifier / Grant number: BZ0308

Funding source: Beijing Municipal Commission of Science and Technology, the central guiding local special

Award Identifier / Grant number: Z231100007423010

Funding source: Beijing Municipal Administration of Hospitals Incubating Program

Award Identifier / Grant number: PX2022026

  1. Research ethics: The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Institutional Ethics Committee of Beijing Anzhen Hospital of Capital Medical University (approval number: 2019030).

  2. Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards.

  3. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: 1. Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease (BZ0308). 2. Beijing Municipal Commission of Science and Technology, the central guiding local special (Z231100007423010). 3. Dengfeng project of talent training plan of Beijing Medical Management Center (DFL20220601). 4. Beijing Municipal Administration of Hospitals Incubating Program (PX2022026).

  7. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Peng, R, Xie, HN, Zhu, YX, Li, LJ, Du, L, Zheng, J. Prenatal diagnosis of prevalence of the right heart: associated anomalies and outcome predictors. J Ultrasound Med 2014;33:1155–61. https://doi.org/10.7863/ultra.33.7.1155.Search in Google Scholar PubMed

2. Rudolph, AM. Hepatic and ductus venosus blood flows during fetal life. Hepatology 1983;3:254–8. https://doi.org/10.1002/hep.1840030220.Search in Google Scholar PubMed

3. Seravalli, V, Miller, JL, Block-Abraham, D, Baschat, AA. Ductus venosus Doppler in the assessment of fetal cardiovascular health: an updated practical approach. Acta Obstet Gynecol Scand 2016;95:635–44. https://doi.org/10.1111/aogs.12893.Search in Google Scholar PubMed

4. Zhang, Y, Wang, J, Zhao, J, Huang, G, Liu, K, Pan, W, et al.. Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China. Lancet Child Adolesc Health 2023;7:479–89. https://doi.org/10.1016/s2352-4642(23)00051-2.Search in Google Scholar

5. Gao, S, Han, J, Yu, S, Guo, Y, Ruan, Y, Fu, Y, et al.. Comparison of fetal echocardiogram with fetal cardiac autopsy findings in fetuses with congenital heart disease. J Matern Fetal Neonatal Med 2021;34:3844–50. https://doi.org/10.1080/14767058.2019.1700498.Search in Google Scholar PubMed

6. Cardiac screening examination of the fetus: guidelines for performing the ‘basic’ and ‘extended basic’ cardiac scan. Ultrasound Obstet Gynecol 2006;27:107–13. https://doi.org/10.1002/uog.2677.Search in Google Scholar PubMed

7. Donofrio, MT, Moon-Grady, AJ, Hornberger, LK, Copel, JA, Sklansky, MS, Abuhamad, A, et al.. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014;129:2183–242. https://doi.org/10.1161/01.cir.0000437597.44550.5d.Search in Google Scholar PubMed

8. Rychik, J, Ayres, N, Cuneo, B, Gotteiner, N, Hornberger, L, Spevak, PJ, et al.. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr 2004;17:803–10. https://doi.org/10.1016/j.echo.2004.04.011.Search in Google Scholar PubMed

9. Moon-Grady, AJ, Donofrio, MT, Gelehrter, S, Hornberger, L, Kreeger, J, Lee, W, et al.. Guidelines and recommendations for performance of the fetal echocardiogram: an update from the American Society of echocardiography. J Am Soc Echocardiogr 2023;36:679–723. https://doi.org/10.1016/j.echo.2023.04.014.Search in Google Scholar PubMed

10. International Society of Ultrasound in Obstetrics and Gynecology, Carvalho, JS, Allan, LD, Chaoui, R, Copel, JA, Hecher, K, et al.. ISUOG practice guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol 2013;41:348–59. https://doi.org/10.1002/uog.12403.Search in Google Scholar PubMed

11. Kiserud, T, Eik-Nes, SH, Blaas, HG, Hellevik, LR. Ultrasonographic velocimetry of the fetal ductus venosus. Lancet 1991;338:1412–4. https://doi.org/10.1016/0140-6736(91)92720-m.Search in Google Scholar PubMed

12. Jauniaux, E, Jurkovic, D, Campbell, S, Hustin, J. Doppler ultrasonographic features of the developing placental circulation: correlation with anatomic findings. Am J Obstet Gynecol 1992;166:585–7. https://doi.org/10.1016/0002-9378(92)91678-4.Search in Google Scholar PubMed

13. Park, MY, Jung, SE, Byun, JY, Kim, JH, Joo, GE. Effect of beam-flow angle on velocity measurements in modern Doppler ultrasound systems. AJR Am J Roentgenol 2012;198:1139–43. https://doi.org/10.2214/ajr.11.7475.Search in Google Scholar PubMed

14. Bahlmann, F, Wellek, S, Reinhardt, I, Merz, E, Steiner, E, Welter, C. Reference values of ductus venosus flow velocities and calculated waveform indices. Prenat Diagn 2000;20:623–34. https://doi.org/10.1002/1097-0223(200008)20:8<623::aid-pd886>3.3.co;2-u.10.1002/1097-0223(200008)20:8<623::AID-PD886>3.3.CO;2-USearch in Google Scholar

15. Germer, U, Kohl, T, Smrcek, JM, Geipel, A, Berg, C, Krapp, M, et al.. Comparison of ductus venosus blood flow waveform indices of 607 singletons with 133 multiples at 10–14 weeks gestation. An evaluation in uncomplicated pregnancies. Arch Gynecol Obstet 2002;266:187–92. https://doi.org/10.1007/s00404-001-0250-y.Search in Google Scholar

16. Axt-Fliedner, R, Diler, S, Georg, T, Friedrich, M, Diedrich, K. Reference values of ductus venosus blood flow velocities and waveform indices from 10 to 20 weeks of gestation. Arch Gynecol Obstet 2004;269:199–204. https://doi.org/10.1007/s00404-003-0484-y.Search in Google Scholar

17. Gilani, SA, Javaid, A, Bala, AA. Fetal Doppler ultrasound assessment of ductus venosus in a 31–40 [corrected] weeks gestation normal fetus in the Pakistani population. Med Ultrason 2010;12:110–3.Search in Google Scholar

18. Pruksanusak, N, Kor-anantakul, O, Suntharasaj, T, Suwanrath, C, Hanprasertpong, T, Pranpanus, S, et al.. A reference for ductus venosus blood flow at 11–13+6 weeks of gestation. Gynecol Obstet Invest 2014;78:22–5. https://doi.org/10.1159/000362273.Search in Google Scholar

19. Suksai, M, Suwanrath, C, Kor-anantakul, O, Suntharasaj, T, Pruksanusak, N, Geater, A. Ductus venosus blood flow velocity waveforms during the early second trimester of pregnancy in a Thai population. Int J Gynaecol Obstet 2016;133:98–102. https://doi.org/10.1016/j.ijgo.2015.09.021.Search in Google Scholar

20. Kalayci, H, Yilmaz Baran, S, Dogan Durdag, G, Yetkinel, S, Alemdaroglu, S, Ozdogan, S, et al.. Reference values of the ductus venosus pulsatility index for pregnant women between 11 and 13(+6) weeks of gestation. J Matern Fetal Neonatal Med 2020;33:1134–9. https://doi.org/10.1080/14767058.2018.1517152.Search in Google Scholar

21. Tongprasert, F, Srisupundit, K, Luewan, S, Wanapirak, C, Tongsong, T. Normal reference ranges of ductus venosus Doppler indices in the period from 14 to 40 weeks’ gestation. Gynecol Obstet Invest 2012;73:32–7. https://doi.org/10.1159/000329322.Search in Google Scholar

22. Rizzo, G, Capponi, A, Arduini, D, Romanini, C. Ductus venosus velocity waveforms in appropriate and small for gestational age fetuses. Early Hum Dev 1994;39:15–26. https://doi.org/10.1016/0378-3782(94)90066-3.Search in Google Scholar PubMed

23. Rizzo, G, Capponi, A, Talone, PE, Arduini, D, Romanini, C. Doppler indices from inferior vena cava and ductus venosus in predicting pH and oxygen tension in umbilical blood at cordocentesis in growth-retarded fetuses. Ultrasound Obstet Gynecol 1996;7:401–10. https://doi.org/10.1046/j.1469-0705.1996.07060401.x.Search in Google Scholar PubMed

24. Sanz, J, Sanchez-Quintana, D, Bossone, E, Bogaard, HJ, Naeije, R. Anatomy, function, and Dysfunction of the right ventricle: JACC state-of-the-art review. J Am Coll Cardiol 2019;73:1463–82. https://doi.org/10.1016/j.jacc.2018.12.076.Search in Google Scholar PubMed

25. Matias, A, Huggon, I, Areias, JC, Montenegro, N, Nicolaides, KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10–14 weeks. Ultrasound Obstet Gynecol 1999;14:307–10. https://doi.org/10.1046/j.1469-0705.1999.14050307.x.Search in Google Scholar PubMed

26. Chemla, D, Berthelot, E, Assayag, P, Attal, P, Herve, P. [Pathophysiology of right ventricular hemodynamics]. Rev Mal Respir 2018;35:1050–62. https://doi.org/10.1016/j.rmr.2017.10.667.Search in Google Scholar PubMed

27. Berg, C, Kremer, C, Geipel, A, Kohl, T, Germer, U, Gembruch, U. Ductus venosus blood flow alterations in fetuses with obstructive lesions of the right heart. Ultrasound Obstet Gynecol 2006;28:137–42. https://doi.org/10.1002/uog.2810.Search in Google Scholar PubMed

28. Arya, B, Krishnan, A, Donofrio, MT. Clinical utility of ductus venosus flow in fetuses with right-sided congenital heart disease. J Ultrasound Med 2014;33:1563–71. https://doi.org/10.7863/ultra.33.9.1563.Search in Google Scholar PubMed


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/jpm-2024-0577).


Received: 2024-12-04
Accepted: 2025-01-20
Published Online: 2025-02-06
Published in Print: 2025-05-26

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Vasa previa guidelines and their supporting evidence
  4. Fetal origins of adult disease: transforming prenatal care by integrating Barker’s Hypothesis with AI-driven 4D ultrasound
  5. Original Articles – Obstetrics
  6. Postpartum remote blood pressure monitoring and risk of hypertensive-related readmission: systematic review and meta-analysis of randomized controlled trials
  7. Proposal of a novel index in assessing perinatal mortality in prenatal diagnosis of Sacrococcygeal teratoma
  8. Maternity staff views on implementing a national perinatal mortality review tool: understanding barriers and facilitators
  9. Prenatal care for twin pregnancies: analysis of maternal and neonatal morbidity and mortality
  10. Hematological indicators and their impact on maternal and neonatal outcomes in pregnancies with thalassemia traits
  11. The reference ranges for fetal ductus venosus flow velocities and calculated waveform indices and their predictive values for right heart diseases
  12. Risk factors and outcomes of uterine rupture before onset of labor vs. during labor: a multicenter study
  13. Feasibility and reproducibility of speckle tracking echocardiography in routine assessment of the fetal heart in a low-risk population
  14. Enhancing external cephalic version success: insights from an Israeli tertiary center
  15. Original Articles – Fetus
  16. Comparative sonographic measurement of the fetal thymus size in singleton and twin pregnancies
  17. Transversal cardiac diameter is increased in fetuses with dextro-transposition of the great arteries older than 28th weeks of gestation
  18. Short Communications
  19. Severe maternal morbidity in twin pregnancies: the impact of body mass index and gestational weight gain
  20. Trends in gestational age and short-term neonatal outcomes in the United States
  21. Letter to the Editor
  22. Mechanisms of hypoxaemia in late pulmonary hypertension associated with bronchopulmonary dysplasia
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2024-0577/html?lang=en
Scroll to top button